Pascal Touchon's most recent trade in Atara Biotherapeutics Inc was a trade of 7,828 Common Stock done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | Pascal Touchon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 7,828 | 77,955 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 16 Aug 2024 | 2,762 | 70,403 (0%) | 0% | 6.6 | 18,309 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 16 Aug 2024 | 276 | 70,127 (0%) | 0% | 6.6 | 1,830 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 12 Aug 2024 | 9,680 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 12 Aug 2024 | 9,000 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 12 Aug 2024 | 7,075 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 16 May 2024 | 81,506 | 1,829,146 (3%) | 0% | 0.6 | 50,289 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 04 Mar 2024 | 24,844 | 1,910,652 (3%) | 0% | 0.7 | 17,888 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 08 Jan 2024 | 1,280,000 | 1,935,496 (3%) | 2% | 0 | Common Stock | ||
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 27 Jun 2023 | 14,291 | 706,671 (1%) | 0% | 1.7 | 23,723 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 16 May 2023 | 29,766 | 720,962 (1%) | 0% | 2.0 | 60,633 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 02 Mar 2023 | 15,679 | 750,728 (1%) | 0% | 3.6 | 56,868 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 01 Mar 2023 | 730,600 | 730,600 | - | - | Employee Stock Option (Right to Buy) | ||
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 01 Mar 2023 | 324,711 | 766,407 (1%) | 0% | 0 | Common Stock | ||
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 16 Aug 2022 | 14,806 | 457,287 (0%) | 0% | 5.0 | 74,548 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 27 Jun 2022 | 14,220 | 472,093 (0%) | 0% | 7.2 | 102,384 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 17 May 2022 | 13,913 | 486,313 (0%) | 0% | 5.3 | 73,962 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 01 Mar 2022 | 339,419 | 339,419 | - | - | Employee Stock Option (Right to Buy) | ||
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 01 Mar 2022 | 180,565 | 509,054 (0%) | 0% | 0 | Common Stock | ||
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 01 Mar 2022 | 8,828 | 500,226 (0%) | 0% | 9.9 | 87,009 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 16 Nov 2021 | 8,402 | 328,489 (0%) | 0% | 17.1 | 143,816 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | 17 Aug 2021 | 8,223 | 336,891 (0%) | 0% | 12.5 | 103,051 | Common Stock |